<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4310092/" ref="ordinalpos=3066&amp;ncbi_uid=7161195&amp;link_uid=PMC4310092" image-link="/pmc/articles/PMC4310092/figure/f7/" class="imagepopup">Figure 7. The effects of miR-148b on the downstream <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> of WNT1..  From: MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1/β-catenin <span class="highlight" style="background-color:">pathway</span>. </a></div><br /><div class="p4l_captionBody">HepG2 cells were transfected with miR-148b or miR-NC for 48 h, the expression levels of β-catenin, C-myc and E-cadherin proteins in HepG2 cells were detected by western blotting. The results were standardized against the levels of GAPDH and repeated three times, *P &lt; 0.05, **P &lt; 0.01.</div></div>